NCT03093545View on ClinicalTrials.gov

Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Rabies
Interventions
BIOLOGICAL

Equine Rabies Immunoglobulin

40 IU per kg of body weight of ERIG at Day 0

BIOLOGICAL

Purified chick-embryo cell rabies vaccine

1 ml of PCEC Rabies vaccine on days 0, 3, 7, 14 and 28.

Trial Locations (1)

10700

Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok

All Listed Sponsors
collaborator

VINS Bioproducts Ltd.

UNKNOWN

collaborator

Biogentech Co.,LTD

UNKNOWN

lead

Mahidol University

OTHER

NCT03093545 - Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients | Biotech Hunter | Biotech Hunter